Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.
about
Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulationOverexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomasMenin determines K-RAS proliferative outputs in endocrine cellsThe Ras-association domain family (RASSF) members and their role in human tumourigenesis.Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors.Silencing of RASSF3 by DNA hypermethylation is associated with tumorigenesis in somatotroph adenomas.The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature.Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cellsRASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.Clinical utility of RASSF1A methylation in human malignancies.Cubic regression-based degree of correction predicts the performance of whole bisulfitome amplified DNA methylation analysis.Animal models of pituitary neoplasiaCoregulation and modulation of NFκB-related genes in celiac disease: uncovered aspects of gut mucosal inflammation.Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenomaLong non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.hTERT promoter methylation in pituitary adenomas.Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas
P2860
Q24655168-5017CAF0-B0AE-4F58-A01F-7F1836AE500DQ28306491-6E1287A9-86D2-4B01-A970-212050F655FDQ28589291-81E1827F-B59C-46FC-9B9D-8765BA871459Q31121564-59AE11BB-CA70-456E-9666-42F778042A79Q33991964-6D24FC4C-1977-4E65-915A-7A4227FD6B35Q34650707-A42ADFF6-ACE1-42CF-B3F6-2507E581A948Q35075351-8AD67A96-9646-46AC-907F-8872DB1F18D2Q35757201-305BE5C2-6083-4B60-A075-66F90D477990Q35891000-23E14647-E464-4895-858E-6DFDFF62DF5BQ35909621-2EB25289-35BA-4637-86F5-8804ADF46F7EQ36484114-0008F361-FAD1-4D48-8AFC-3756D48B92EFQ36486988-8CC2041B-38B4-47EF-A3B4-5ED99E922D3EQ37572161-4822000E-39B2-49F2-89F9-B5B4AAE51D55Q37619445-D1E7FC22-E161-461F-9328-4F26D3D8F629Q38705928-3E4A7A7D-C3B3-4538-8D9C-557D9106DF51Q52149001-81B2E290-6A31-48DB-9503-8594CA434188Q57794449-A95BF110-733A-4671-B184-45B2B7EB6B49
P2860
Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@en
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@nl
type
label
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@en
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@nl
prefLabel
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@en
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@nl
P2093
P2860
P1476
Inactivation of RASSF1A tumor ...... n in human pituitary adenomas.
@en
P2093
Akira Ishizuka
Hidehisa Horiguchi
Katsuhiko Yoshimoto
Mitsuyoshi Hirokawa
Noriko Mizusawa
Shozo Yamada
Toshiaki Sano
P2860
P2888
P304
P356
10.1038/LABINVEST.3700248
P577
2005-04-01T00:00:00Z